These resources can help answer questions and provide a better understanding of the treatment, including its benefits and potential side effects
Li S, Liu M, Chen J, Chen Y, Yin M, Zhou Y, Li Q, Xu F, Li Y, Yan X, et al
Monica, James, et al
Your doctor will review your current medications, overall health and treatment goals to determine whether GLP-1 therapy is appropriate
Other companies are working on their own weight-loss pills: Eli Lilly, which makes Zepbound, is developing a GLP-1 pill, orforglipron, for weight loss and type 2 diabetes, with FDA approval anticipated for March 2026
Dose: 2 mg (2000 mcg) daily after Week 1 titration